During the past decade, WellStar Research Institute conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 5 clinical trials were completed, i.e. on average, 62.5% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 4 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "WellStar Research Institute" #1 sponsor was "Boston Scientific Corporation" with 3 trials, followed by "Rapid Medical" with 2 trials sponsored, "Abiomed Inc." with 1 trials sponsored, "Genentech, Inc." with 1 trials sponsored and "Liquidia Technologies, Inc." with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "WellStar Research Institute" #1 collaborator was "Beth Israel Deaconess Medical Center" with 1 trials as a collaborator, "Biomedical Advanced Research and Development Authority" with 1 trials as a collaborator, "Milton S. Hershey Medical Center" with 1 trials as a collaborator, "Nuventra, Inc." with 1 trials as a collaborator and "Stryker Neurovascular" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "WellStar Research Institute" are "Ischemic Stroke" (2 trials), "Aortic Valve Stenosis" (1 trials), "Atrial Fibrillation" (1 trials), "Atrial Fibrillation New Onset" (1 trials) and "Bradycardia" (1 trials). Many other conditions were trialed in "WellStar Research Institute" in a lesser frequency.

Most popular intervention types in "WellStar Research Institute" are "Device" (7 trials) and "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "ABIOMED, Inc. hemodynamic support devices" (1 trials), "Antiarrhythmic drug" (1 trials), "COGNIS CRT-D" (1 trials), "Cryoablation" (1 trials) and "INGEVITY lead" (1 trials). Other intervention names were less common.

The vast majority of trials in "WellStar Research Institute" are 11 trials for "All" genders.

Currently, there are NaN active trials in "WellStar Research Institute". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in WellStar Research Institute, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in WellStar Research Institute, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".